Target intelligence / Profile preview

Gut microbiota community composition

Molecular classification
Other
01

Overview

The gut microbiota community composition refers to the complex and dynamic ecosystem of trillions of microorganisms, including bacteria, archaea, fungi, and viruses, inhabiting the human gastrointestinal tract [1]. This community functions as a virtual organ that is essential for the fermentation of non-digestible dietary fibers, the synthesis of vitamins such as B12 and K, and the maintenance of the intestinal mucosal barrier [2]. It plays a pivotal role in host health by modulating the immune system and protecting against pathogen colonization through competitive exclusion and the production of antimicrobial peptides [3]. Dysbiosis, or the pathological imbalance of this community, is implicated in a broad spectrum of diseases, including Clostridioides difficile infection (CDI), inflammatory bowel disease (IBD), and metabolic disorders like type 2 diabetes [4]. Therapeutic strategies targeting the microbiota include fecal microbiota transplants (FMT), live biotherapeutic products (LBPs), and prebiotics, which aim to restore a healthy microbial balance and diversity [5]. Unlike traditional single-molecule targets, the gut microbiota is targeted as a collective system to alter the host's physiological, metabolic, and immunological landscape [6].

Other names
Gut microbiomeIntestinal microfloraGastrointestinal microbiotaCommensal gut community
02

Mechanism of action

Restoration of microbial diversity and ecological homeostasis to suppress pathogens and modulate host metabolic and immune pathways.

03

Biological functions

Metabolic regulationImmune system modulationPathogen exclusionVitamin synthesisNeurotransmitter production
04

Disease associations

InfectionInflammationMetabolic diseaseNeurodegenerative diseaseCancer
05

Safety considerations

Potential for pathogen transmission from donorsRisk of bacteremia in immunocompromised patientsUnpredictable shifts in host metabolismHorizontal gene transfer of antibiotic resistance factors
06

Interacting drugs

Fecal microbiota spores, live-brpk (SER-109)

5 more in the full profile.

07

Biomarkers

Shannon diversity indexBeta diversityFirmicutes/Bacteroidetes ratioFecal short-chain fatty acid (SCFA) concentration

Beyond the preview

Go deeper on Gut microbiota community composition.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gut microbiota community composition.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call